Rule-in thresholds for DELFIA Xpress PlGF 1-2-3 test for suspected pre-eclampsia.


Journal

Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 09 03 2020
revised: 11 04 2020
accepted: 20 04 2020
pubmed: 11 5 2020
medline: 28 5 2021
entrez: 11 5 2020
Statut: ppublish

Résumé

We aimed to establish a rule-in threshold for the DELFIA Xpress placental growth factor (PlGF) 1-2-3 test. Plasma EDTA samples from 305 women presenting with suspected pre-eclampsia before 35 weeks' gestation were analysed using three different PlGF-based tests: PlGF 1-2-3 test (Perkin Elmer); Triage PlGF test (Quidel); Elecsys immunoassay sFlt-1/PlGF ratio (Roche). The rule-in threshold for PlGF 1-2-3 test created with equivalent specificity of the Quidel and Roche tests was 50 pg/ml. This can be used as a rule-in test for diagnosis of preterm pre-eclampsiarequiring delivery within 14 days (specificity 95.0% (95% CI 91.7-97.2%), positive predictive value50 (95% CI 30.6-69.4%), positive likelihood ratio 10.7 (5.8-20).

Identifiants

pubmed: 32388118
pii: S2210-7789(20)30043-X
doi: 10.1016/j.preghy.2020.04.005
pii:
doi:

Substances chimiques

Biomarkers 0
PGF protein, human 0
Placenta Growth Factor 144589-93-5

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-37

Subventions

Organisme : Department of Health
ID : RP-2014-05-019
Pays : United Kingdom

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Lucie Giblin (L)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: Lucie.1.giblin@kcl.ac.uk.

Fergus P McCarthy (FP)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: fergus.mccarthy@ucc.ie.

Carolyn Gill (C)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: carolyn.gill@kcl.ac.uk.

Paul T Seed (PT)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: Paul.seed@kcl.ac.uk.

Kate Bramham (K)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: kate.bramham@kcl.ac.uk.

Anna Brockbank (A)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: anna.brockbank@kcl.ac.uk.

Lucy C Chappell (LC)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: Lucy.chappell@kcl.ac.uk.

Andrew H Shennan (AH)

Women's Health Academic Centre, St Thomas' Hospital, King's College London, United Kingdom. Electronic address: Andrew.shennan@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH